Cargando…

Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study

BACKGROUND: Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). METHODS: Age-standardized rates (ASRs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Ming, Zhou, Hongming, Li, Yushi, Jin, Hai, Liu, Xiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722328/
https://www.ncbi.nlm.nih.gov/pubmed/34980239
http://dx.doi.org/10.1186/s13075-021-02705-6
_version_ 1784625506361016320
author Fu, Ming
Zhou, Hongming
Li, Yushi
Jin, Hai
Liu, Xiqing
author_facet Fu, Ming
Zhou, Hongming
Li, Yushi
Jin, Hai
Liu, Xiqing
author_sort Fu, Ming
collection PubMed
description BACKGROUND: Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). METHODS: Age-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years. RESULTS: Globally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29–0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27–0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60–64-year-old age group, whereas the DALYs increased with age. CONCLUSIONS: The incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02705-6.
format Online
Article
Text
id pubmed-8722328
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87223282022-01-06 Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study Fu, Ming Zhou, Hongming Li, Yushi Jin, Hai Liu, Xiqing Arthritis Res Ther Research Article BACKGROUND: Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). METHODS: Age-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years. RESULTS: Globally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29–0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27–0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60–64-year-old age group, whereas the DALYs increased with age. CONCLUSIONS: The incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02705-6. BioMed Central 2022-01-03 2022 /pmc/articles/PMC8722328/ /pubmed/34980239 http://dx.doi.org/10.1186/s13075-021-02705-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Fu, Ming
Zhou, Hongming
Li, Yushi
Jin, Hai
Liu, Xiqing
Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study
title Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study
title_full Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study
title_fullStr Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study
title_full_unstemmed Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study
title_short Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study
title_sort global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 global burden of disease study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722328/
https://www.ncbi.nlm.nih.gov/pubmed/34980239
http://dx.doi.org/10.1186/s13075-021-02705-6
work_keys_str_mv AT fuming globalregionalandnationalburdensofhiposteoarthritisfrom1990to2019estimatesfromthe2019globalburdenofdiseasestudy
AT zhouhongming globalregionalandnationalburdensofhiposteoarthritisfrom1990to2019estimatesfromthe2019globalburdenofdiseasestudy
AT liyushi globalregionalandnationalburdensofhiposteoarthritisfrom1990to2019estimatesfromthe2019globalburdenofdiseasestudy
AT jinhai globalregionalandnationalburdensofhiposteoarthritisfrom1990to2019estimatesfromthe2019globalburdenofdiseasestudy
AT liuxiqing globalregionalandnationalburdensofhiposteoarthritisfrom1990to2019estimatesfromthe2019globalburdenofdiseasestudy